The administration of tempol, which has SOD activity, decreased oxidative markers along with the regulation of antioxidant enzyme expression in the skeletal muscle of a mouse model of Duchenne muscular dystrophy [8]. Here, SOD1 is linked to Duchenne muscular dystrophy.